Literature DB >> 26558942

Long Non-Coding RNA Urothelial Carcinoma Associated 1 (UCA1): Insight into Its Role in Human Diseases.

Feng Li1, Chang-Ping Hu1.   

Abstract

Long non-coding RNA (lncRNA) is a type of DNA transcript that is longer than 200 nucleotides (nt). They do not encode proteins, but they control gene expression on various levels. Long non-coding RNA metastasis-associated urothelial carcinoma associated 1 (UCA1) was confirmed to play an important role in the occurrence and development of many tumor and non-tumor diseases. UCA1 mainly interacts with proteins in the nucleus, regulating gene expression in transcription and post-transcription. UCA1 is highly expressed in tumor tissue, and therefore can be related to clinical parameters. It may regulate tumor cell proliferation, invasion, apoptosis, and migration, so UCA1 can be applied in clinical prognosis and targeted therapy. This review mainly elaborates the roles of UCA1 in tumor diseases of the respiratory, digestive, reproductive, and urinary systems; and in non-tumor diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26558942     DOI: 10.1615/critreveukaryotgeneexpr.2015013770

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  11 in total

1.  Downregulation of lncRNA TUBA4B is Associated with Poor Prognosis for Epithelial Ovarian Cancer.

Authors:  Fang-Fang Zhu; Fei-Yun Zheng; Hai-Ou Wang; Jing-Jie Zheng; Qian Zhang
Journal:  Pathol Oncol Res       Date:  2017-06-03       Impact factor: 3.201

Review 2.  Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review.

Authors:  Hilda Samimi; Sayed Mahmoud Sajjadi-Jazi; Soroush Seifirad; Rasha Atlasi; Habibollah Mahmoodzadeh; Mohammad Ali Faghihi; Vahid Haghpanah
Journal:  Cancer Cell Int       Date:  2020-07-29       Impact factor: 5.722

3.  Prognostic and clinicopathological role of long non-coding RNA UCA1 in various carcinomas.

Authors:  Xiaoxiong Wang; Fei Peng; Liang Cheng; Guang Yang; Daming Zhang; Jiaqi Liu; Xin Chen; Shiguang Zhao
Journal:  Oncotarget       Date:  2017-04-25

4.  Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.

Authors:  Congmin Liu; Jing Jin; Jin Shi; Liqun Wang; Zhaoyu Gao; Tiantian Guo; Yutong He
Journal:  Biosci Rep       Date:  2019-04-26       Impact factor: 3.840

Review 5.  Long Non-coding RNA in Neuronal Development and Neurological Disorders.

Authors:  Ling Li; Yingliang Zhuang; Xingsen Zhao; Xuekun Li
Journal:  Front Genet       Date:  2019-01-23       Impact factor: 4.599

6.  Urothelial carcinoma associated 1 promotes trophoblast invasion by regulating MMP9.

Authors:  Hongfang Shao; Feng Jin; Jiangshan Hu; Zhangying Zhu; Fuju Tian; Minfang Tao; Yincheng Teng
Journal:  Cell Biosci       Date:  2019-09-23       Impact factor: 7.133

7.  LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146.

Authors:  Liping Shan; Wei Liu; Yunhong Zhan
Journal:  Cancer Cell Int       Date:  2021-07-08       Impact factor: 5.722

8.  Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway.

Authors:  Chengyun Li; Geyu Liang; Sheng Yang; Jing Sui; Wenzhuo Yao; Xian Shen; Yanqiu Zhang; Hui Peng; Weiwei Hong; Siyi Xu; Wenjuan Wu; Yancheng Ye; Zhiyi Zhang; Wenhua Zhang; Lihong Yin; Yuepu Pu
Journal:  Oncotarget       Date:  2017-07-17

9.  Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition.

Authors:  Junfeng Wu; Wei Li; Jinzhuo Ning; Weimin Yu; Ting Rao; Fan Cheng
Journal:  Onco Targets Ther       Date:  2019-01-09       Impact factor: 4.147

10.  lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143.

Authors:  Yanlan Yu; Fengbin Gao; Qian He; Gonghui Li; Guoqing Ding
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-27       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.